We revealed that restoring FAM107A expression in prostate cancer cell lines such as DU 145 and PC 3 inhibited cell cycle progression, increased the proportion of cells in G1, and inhibited the expression of cyclin D1, a key protein in the G1 phase. The gene discussed is FAM107A; the disease is prostate carcinoma.